Skip to main content

Physician Resource Center

Featured Content View More

Don’t Miss Roswell Park at AUA News

Don’t Miss Roswell Park at AUA

Roswell Park Comprehensive Cancer Center is proud to highlight seven experts who will be presenting their new research at this year’s Annual Meeting of the American Urological Association, May 15-16 in Washington, DC.

Roswell Park Study: Inhibiting Regulator Protein Can Make Aggressive Prostate Cancers More Vulnerable News

Roswell Park Study: Inhibiting Regulator Protein Can Make Aggressive Prostate Cancers More Vulnerable

Team shows BCL-2 promotes treatment resistance, uncovering strategy for making tumors respond to treatment.

Roswell Park Experts Highlight Untapped Potential of CDK Inhibitor Cancer Therapy News

Roswell Park Experts Highlight Untapped Potential of CDK Inhibitor Cancer Therapy

Worldwide, more than a million breast cancer patients have been treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, which slow or stop the uncontrolled multiplication of cancer cells.

New Research Sheds Light on How Precancerous Lesions Form in the Pancreas News

New Research Sheds Light on How Precancerous Lesions Form in the Pancreas

Discoveries about two metabolic enzymes could point the way to biomarkers, opportunities to prevent cancer.

First-in-Human Clinical Trial Evaluates Bispecific Antibody for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma News

First-in-Human Clinical Trial Evaluates Bispecific Antibody for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Roswell Park Comprehensive Cancer Center is one of only five sites in the U.S. offering a first-in-human clinical trial to gauge the safety and anti-tumor activity of LTZ-301 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (NHL).

MimiVax and Roswell Park Open Phase 2 Trial of SurVaxM for Patients with Metastatic Neuroendocrine Tumors News

MimiVax and Roswell Park Open Phase 2 Trial of SurVaxM for Patients with Metastatic Neuroendocrine Tumors

Clinical study marks SurVaxM’s second phase 2 trial in a major cancer indication

This site is intended for healthcare professionals

RPMD App
Access wherever you go

Click your preferred app store below to download our free mobile app — exclusively for physicians and physician offices — for direct access to a complete, up-to-date directory of Roswell Park physicians wherever you go. Email or call to refer a patient or ask a question with a click of a button.

Upcoming Physician & Research Events

Buffalo RNA Symposium 2025

June 11, 2025 | Buffalo, NY

5th Translational Genomics & Epigenomics Symposium

September 18-19, 2025 | Buffalo, NY


Powered by BroadcastMedBROADCASTMED
BroadcastMed Privacy Policy